Episodit
-
Puuttuva jakso?
- Näytä enemmän
Dr. Jack West reviews the trial design of the MYSTIC trial of durvalumab alone or in combination with tremelimumab, what we know about results, and the implications for the current & future landscape in NSCLC.
Puuttuva jakso?